![](/img/cover-not-exists.png)
Identification of early antigen BZLF1/ZEBRA protein of Epstein–Barr virus can predict the effectiveness of antiviral treatment in patients with post-transplant lymphoproliferative disease
Stephan H. Oertel, Ioannis Anagnostopoulos, Manfred W. Hummel, Sven Jonas, Hanno B. RiessVolume:
118
Year:
2002
Language:
english
Pages:
4
DOI:
10.1046/j.1365-2141.2002.03764.x
File:
PDF, 57 KB
english, 2002